Citation Impact
Citing Papers
Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps
2019
Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study
2018
Current State of Preeclampsia Mouse Models: Approaches, Relevance, and Standardization
2021
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
2018
Non-alcoholic fatty liver disease – A global public health perspective
2018 Standout
A decision analysis study of the value of a liver biopsy in nonalcoholic steatohepatitis
2008
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
2020 Standout
Environmental pesticide exposure modulates cytokines, arginase and ornithine decarboxylase expression in human placenta
2013
Hallmarks of aging: An expanding universe
2023 Standout
Hepatocellular adenoma: Classification, variants and clinical relevance
2016
Hepatocellular carcinoma
2021 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Use of Liver Imaging and Biopsy in Clinical Practice
2017
Noninvasive biomarkers in NAFLD and NASH — current progress and future promise
2018
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials
2020
Non-alcoholic fatty liver disease
2021 Standout
CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator
2008
Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date
2019
The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives
2020 Standout
Global burden of liver disease: 2023 update
2023 Standout
Negative regulators of T‐cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections
2009 StandoutNobel
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
2008 Standout
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
2016
Clinical trial: insulin‐sensitizing agents may reduce consequences of insulin resistance in individuals with non‐alcoholic steatohepatitis
2008
Overlooked subclinical portal hypertension in non-cirrhotic NAFLD: Is it real and how to measure it?
2021
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Report on the AASLD/EASL joint workshop on clinical trial endpoints in NAFLD
2019
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
2005 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy
2023 StandoutNobel
Physical activity levels and hepatic steatosis: A longitudinal follow‐up study in adults
2017
Orthogonal Design of Experiments for Engineering of Lipid Nanoparticles for mRNA Delivery to the Placenta
2023 StandoutNobel
Anastomosing Hemangioma: Short Review of a Benign Mimicker of Angiosarcoma
2019
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
HydraPsiSeq: a method for systematic and quantitative mapping of pseudouridines in RNA
2020
Low Levels of Alcohol Consumption, Obesity, and Development of Fatty Liver With and Without Evidence of Advanced Fibrosis
2019
Premature aging in mice with error-prone protein synthesis
2022
EASL Clinical Practice Guidelines: Management of alcohol-related liver disease
2018
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
2020
The Broad Scope of Health Effects from Chronic Arsenic Exposure: Update on a Worldwide Public Health Problem
2013 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
2023 Standout
Report on the AASLD/EASL Joint Workshop on Clinical Trial Endpoints in NAFLD
2019
Nonalcoholic Steatohepatitis
2020
Nonalcoholic Fatty Liver Disease: Pathologic Patterns and Biopsy Evaluation in Clinical Research
2012
A systematic dissection of determinants and consequences of snoRNA-guided pseudouridylation of human mRNA
2022 StandoutNobel
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
2011 StandoutNobel
Arsenic-Associated Oxidative Stress, Inflammation, and Immune Disruption in Human Placenta and Cord Blood
2010
NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management
2019
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Natural history of NASH and HCC
2020
Works of Ryan M. Gill being referenced
Differential cellular expression of LIGHT and its receptors in early gestation human placentas
2006
Aggressive non-alcoholic steatohepatitis following rapid weight loss and/or malnutrition
2017
Among Patients With Nonalcoholic Fatty Liver Disease, Modest Alcohol Use Is Associated With Less Improvement in Histologic Steatosis and Steatohepatitis
2018
Correlation of exon 3 β-catenin mutations with glutamine synthetase staining patterns in hepatocellular adenoma and hepatocellular carcinoma
2016
Immunoregulatory molecules in human placentas: potential for diverse roles in pregnancy
2009
A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease
2016
Nonalcoholic Steatohepatitis
2013
Association between cytokines and liver histology in children with nonalcoholic fatty liver disease
2017
Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease
2016
Centrizonal Arteries and Microvessels in Nonalcoholic Steatohepatitis
2011
Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease
2019
Low Testosterone Is Associated With Nonalcoholic Steatohepatitis and Fibrosis Severity in Men
2019
Recurrent GNAQ mutations in anastomosing hemangiomas
2017
Differential Expression of LIGHT and Its Receptors in Human Placental Villi and Amniochorion Membranes
2002
A single H/ACA small nucleolar RNA mediates tumor suppression downstream of oncogenic RAS
2019
Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis
2019